Background. Acinetobacter baumannii is an important agent of healthcare-acquired infections, sporting high resistance to major antibiotics in acute care. Since A. baumannii is an opportunistic pathogen commonly found in the environment, we aimed to investigate: (1) its prevalence as colonizer on patients, environment, and healthcare personnel (HCP) in Nursing Facilities (NFs) with intermediate intensity of care but high antibiotic pressure and (2) whether resistance rates in colonizing strains vary between patient, environmental, and HCP isolates.
Methods. We analyzed A. baumannii patient and HCP colonization and environmental contamination in six NFs in Michigan. Samples were collected from HCPs hands, and from multiple patient body sites and high-touch surfaces at admission, 14 days, and monthly up to 6 months. Ciprofloxacin, imipenem, and ceftazidime resistance was tested according to CLSI guidelines.
Results. 651 patients were screened (average follow-up time was 29 days). Patient colonization with A. baumannii was found in 59/1,620 (3.64%) of visits, and environmental contamination in 267/1,620 visits (16.48%) (P < 0.001). Interestingly, HCP showed at least as high or possibly higher colonization rates than patients (32/574) (5.25%) (P = 0.06). Resistance rates differed significantly between HCP, environmental, and patient isolates, ranging from 35 to 38% for patient isolates, 26 to 30% for environmental isolates, and only 8 to 17% for HCP isolates (table). Background. Congregate settings may facilitate spread of USA300. Jails may be a location where individuals already colonized with MRSA (from preceding exposures) intermingle with others, potentially augmenting spread. We examined the rate of MRSA acquisition during incarceration and characterized the genomic epidemiology of MRSA strains entering the jail, MRSA acquisition isolates, and archived (2015) (2016) (2017) clinical MRSA isolates from male detainees.
Methods. Males incarcerated at the Cook County Jail were enrolled within 72 hours of intake and surveillance cultures for MRSA carriage (nares, throat, groin) collected. Detainees in jail at Day 30 had cultures repeated to determine MRSA acquisition. A survey was administered and chart review performed to identify predictors of acquisition. Whole-genome sequencing and phylogenetic analysis of isolates were performed with integration of epidemiologic data.
Results. 800 males were enrolled, with 19% colonized with MRSA at jail intake. 143 reached the Day30 visit (82% AA, 7% Hispanic), by which there were 12 MRSA acquisitions detected. Heroin use before entering the jail (OR 3.67, P = 0.04) and sharing personal items during incarceration (OR = 4.92, P = .01) were significant predictors of acquisition. Sequenced clinical isolates (n = 175) (largely skin infections) were more likely to resemble each other genetically than the diverse intake strains (P < 0.001) (figure), suggesting clinical isolates may originate from transmission within the jail or be due to more virulent strains. 7/12 (58%) acquisition isolates were within 40 SNVs from another isolate; five were genomically similar to intake isolates and two were similar to clinical isolates. Acquisition strains from those sharing personal items (vs. not) tended to have closer relatedness (19 SNVs vs. 56 SNVs, P = 0.22).
Conclusion. There is a high burden of MRSA entering jail. Genomic analysis of acquisition and clinical isolates suggests potential spread of incoming strains and possible networks spread of prevalent strains during incarceration. Sharing of personal items during incarceration is associated with MRSA acquisition and could be a focus of an intervention. Future study of epidemiologic and location data may inform targeting of interventions within the jail. Background. Typical Infection Prevention to detect pathogen transmission in hospitals has relied on observation of (1) uncommon pathogen phenotypes or (2) greater than expected number of pathogen phenotypes in a given timeframe and/ or location. Genome sequencing of targeted organisms in conjunction with routine patient geo-temporal information and antibiotic susceptibility data holds promise in identifying transmissions with greater sensitivity and specificity, saving time and effort in reviewing for transmission events.
Methods. In an on-going genomic sequencing surveillance effort in a tertiary care hospital, drug-resistant clinical isolates from the "ESKAPE" pathogens were routinely sequenced in 2017. In parallel, potential clusters were identified for 2017 through conventional Infection Prevention approaches. Groups identified by their genetic distances along with visualizations on antimicrobial susceptibilities, and patient location histories and dates were displayed in an interactive interface, Philips IntelliSpace Epidemiology (PIE), and reviewed by Infection Prevention.
Results. Among 656 patients, 1,239 drug-resistant ESKAPE samples were sequenced. Thirty-eight genetically related groups involving 196 patients were identified. Groups ranged in size from two to 44 patients, primarily consisting of VRE and MRSA. Notably, a review of the 38 groups identified 20 groups where the information at hand suggested a concern for transmission. 16 of the 20 were not previously identified by Infection Prevention. Using PIE to review all 38 groups identified from 1 year's worth of data required 3 hours of time by an Infection Prevention professional, averaging less than 5 minutes per cluster, less than 1 minute per patient, and 11 minutes of review time per actionable opportunity. By conventional means, approximately 23 hours would have been required to review the genomic groups without the aid of the PIE tool.
Conclusion. The use of PIE's genomic-defined groups, along with the integrated clinical data platform, allows for a greater ability, certainty, and speed to detect clusters of organisms representing transmission in the hospital setting. Applied prospectively, PIE can detect transmissions sooner than by conventional means for potential patient safety gains and cost savings. Background. Despite the global threat of CRE, data from resource-limited regions such as the Dominican Republic (DR) are limited. A lack of novel antibiotics and molecular diagnostic tools for outbreak detection, coupled with the role of travel in circulating CRE to and from the DR represent significant challenges to limiting their spread. Here, we report the first molecular characterization of DR CRE isolates and compared them to geographically diverse CRE.
Emergence of Diverse
Methods. Isolates from DR (one Citrobacter freundii, three Klebsiella pneumoniae), obtained from patients with bacteremia (one) and pneumonia (three), were compared with CRE from a New York City hospital in a Dominican neighborhood, including isolates (two Enterobacter cloacae, one K. pneumoniae) from a patient transferred to NYC from another DR institution. Whole genome sequencing was used to determine multi-locus sequence type (MLST) and resistance gene profiles. Phylogenetic analyses of isolates with same ST were performed.
Results. Isolates from the DR and the Dominican patient were of unique genomic backgrounds including pandemic (K. pneumoniae ST11) and novel sequence types, and harbored either bla KPC-2 or bla (Table 1 ). Replicon typing suggested that these carbapenemase genes were located on distinct plasmids. Phylogenetic analyses using the NYC collection of ~400 sequenced CRE isolates indicated that DR and NYC K. pneumoniae ST307 isolates were related (33 SNPs). Further review showed that both patients had recent admissions in Puerto Rico (PR), highlighting the role of regional spread. K. pneumoniae ST11 isolates from DR and NYC, on the other hand, were not found to be closely related (1,418-1,440 SNPs).
Conclusion. Genotyping of DR CRE isolates revealed a high genomic diversity, suggesting multiple introductions. Phylogenetics of K pneumoniae ST307 place these within a global context, demonstrating links across the Caribbean and North America. International surveillance studies integrating genomics are needed to track and limit the spread of CRE in resource-limited settings such as DR. 
